Gain Therapeutics, Inc.

US$1.03As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GANXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (37.92%)
Div yield —
ROE (268.30%)
Biotechnology
Beta (5Y) 0.30
PE TTM —
TSR TTM (47.45%)
Mkt cap US$44.95M
ROIC (148.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.00
(2.75%)
(7.33%)
Hold 11|5|1|4|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
23.19%
11.11%
13.78%
6.94%
Revenue$M
5.513
5.675
5.799
5.759
4.80%
3.49%
3.04%
2.22%
Peers (US$44.95M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.737
0.077
0.072
EBIT/Intx
1.704
0.264
0.214
Own earn%
14.32
(162.09)
(146.31)
Sh yield%
41.57
41.74
36.90
Owners
Insiders/Inst%
1.02
70.09
Short interest%
1.87
SBC / revenue%
5.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
19–26
$1 testx
−0.1
Incr. ROIC%
3